Cargando…
Ethynylphosphonamidates for the Rapid and Cysteine‐Selective Generation of Efficacious Antibody–Drug Conjugates
Requirements for novel bioconjugation reactions for the synthesis of antibody–drug conjugates (ADCs) are exceptionally high, since conjugation selectivity as well as the stability and hydrophobicity of linkers and payloads drastically influence the performance and safety profile of the final product...
Autores principales: | Kasper, Marc‐André, Stengl, Andreas, Ochtrop, Philipp, Gerlach, Marcus, Stoschek, Tina, Schumacher, Dominik, Helma, Jonas, Penkert, Martin, Krause, Eberhard, Leonhardt, Heinrich, Hackenberger, Christian P. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851832/ https://www.ncbi.nlm.nih.gov/pubmed/31250955 http://dx.doi.org/10.1002/anie.201904193 |
Ejemplares similares
-
N‐Hydroxysuccinimide‐Modified Ethynylphosphonamidates Enable the Synthesis of Configurationally Defined Protein Conjugates
por: Kasper, Marc‐André, et al.
Publicado: (2020) -
Site‐Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy
por: Schwach, Jonathan, et al.
Publicado: (2020) -
Current Status: Site-Specific Antibody Drug Conjugates
por: Schumacher, Dominik, et al.
Publicado: (2016) -
Compact hydrophilic electrophiles enable highly efficacious high DAR ADCs with excellent in vivo PK profile
por: Ochtrop, Philipp, et al.
Publicado: (2023) -
Broad substrate tolerance of tubulin tyrosine ligase enables one-step site-specific enzymatic protein labeling
por: Schumacher, Dominik, et al.
Publicado: (2017)